Real-time enrollment status for this melas syndrome clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT06402123 |
| Recruiting Status | Active, Not Recruiting |
| Condition | MELAS Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 44 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Tisento Therapeutics |
| Last Updated on CT.gov | February 3, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT06402123 is currently active_not_recruiting participants. This clinical trial study for melas syndrome is not currently accepting new participants at 14 locations across the United States. The study is sponsored by Tisento Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06402123 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06402123 was last updated 3 weeks ago (February 3, 2026). HelloStudys verifies this status automatically.